Kenneth Stauderman
Founder at CALCIMEDICA, INC.
Net worth: 63 184 $ as of 2024-04-29
Kenneth Stauderman active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CALCIMEDICA, INC. | Chief Tech/Sci/R&D Officer | 2007-03-31 | - |
| Founder | 2007-03-31 | - | |
CalciMedica, Inc. (US)
 CalciMedica, Inc. (US) BiotechnologyHealth Technology CalciMedica, Inc. is a holding company, which engages in drug development. It discovers and develops novel small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant rejection. The company was founded by Gonul Velicelebi, Kenneth Stauderman, Anjana Rao, Patrick Hogan, Stefan Feske, Michael Harpold, Tom Reed, and Jack Roos in December 2006 and is headquartered in La Jolla, CA. | Chief Tech/Sci/R&D Officer | 2006-11-30 | - |
| Founder | 2009-08-10 | - |
Career history of Kenneth Stauderman
Former positions of Kenneth Stauderman
| Companies | Position | Start | End |
|---|---|---|---|
TorreyPines Therapeutics, Inc.
 TorreyPines Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TorreyPines Therapeutics, Inc. manufactures and distributes biopharmaceutical products. The company develops small molecule drugs to treat diseases and disorders of the central nervous system, chronic pain, neuropathic pain, cognitive disorders and alzheimer's disease. It was formerly known as Axonyx, Inc. The company is headquartered in La Jolla, CA. | Corporate Officer/Principal | 1999-12-31 | 2006-12-31 |
| Sibia Neurosciences, Inc. | Corporate Officer/Principal | 1993-12-31 | 1999-12-31 |
Sanofi-Aventis U.S. LLC
 Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Chief Tech/Sci/R&D Officer | 1985-12-31 | 1993-12-31 |
| Marion Merrell Dow Pharmaceutical, Inc. | Chief Tech/Sci/R&D Officer | - | - |
Training of Kenneth Stauderman
| University of Virginia | Undergraduate Degree |
| Texas University of Health Center at San Antonio | Doctorate Degree |
Statistics
International
| United States | 8 |
| Canada | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 4 |
| Founder | 2 |
| Corporate Officer/Principal | 2 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| CALCIMEDICA, INC. | Health Technology |
| Private companies | 5 |
|---|---|
CalciMedica, Inc. (US)
CalciMedica, Inc. (US) BiotechnologyHealth Technology CalciMedica, Inc. is a holding company, which engages in drug development. It discovers and develops novel small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant rejection. The company was founded by Gonul Velicelebi, Kenneth Stauderman, Anjana Rao, Patrick Hogan, Stefan Feske, Michael Harpold, Tom Reed, and Jack Roos in December 2006 and is headquartered in La Jolla, CA. | Health Technology |
TorreyPines Therapeutics, Inc.
TorreyPines Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TorreyPines Therapeutics, Inc. manufactures and distributes biopharmaceutical products. The company develops small molecule drugs to treat diseases and disorders of the central nervous system, chronic pain, neuropathic pain, cognitive disorders and alzheimer's disease. It was formerly known as Axonyx, Inc. The company is headquartered in La Jolla, CA. | Health Technology |
| Sibia Neurosciences, Inc. | Health Technology |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Health Technology |
| Marion Merrell Dow Pharmaceutical, Inc. |
- Stock Market
- Insiders
- Kenneth Stauderman
- Experience
